Legal & General Group
PRNB

Legal & General Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Legal & General Group’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,674
Closed -$458K – 3453
2020
Q2 		$458K Buy
7,674
+3,971
+107% +$245K ﹤0.01% 2191
2020
Q1 		$220K Sell
3,703
-852
-19% -$49.7K ﹤0.01% 2269
2019
Q4 		$249K Buy
4,555
+2,322
+104% +$86.7K ﹤0.01% 2344
2019
Q3 		$63K Hold
2,233
– – ﹤0.01% 2666
2019
Q2 		$74K Buy
2,233
+1,351
+153% +$42.2K ﹤0.01% 2639
2019
Q1 		$30K Hold
882
– – ﹤0.01% 2937
2018
Q4 		$24K Buy
+882
New +$22.7K ﹤0.01% 3017

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Legal & General Group's PRNB Position: Q3 2020 in Review

Legal & General Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 7,674 shares — an estimated $458K sold.

Legal & General Group first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $458K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Legal & General Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Legal & General Group sold 7,674 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $458K.
  • Legal & General Group first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • Legal & General Group's Principia Biopharma Inc. Common Stock position peaked at $458K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.